HEALTHIER CHOICES MANAGEMENT CORP. financials

HCMC CIK 0000844856

Source: EDGAR filings · Built 2026-06-19T02:28:56Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2024FY 2023FY 2022FY 2021
Free Cash Flow -3.70M -4.92M -4.35M -3.58M
EBITDA -6.99M -8.44M -5.96M -7.59M -4.24M
Working Capital -250.54K -720.36K -505.68K 20.40M 26.25M
Net Debt -1.14M -1.19M 11.21M -9.73M -23.37M
Gross Margin -937.93% -13234.53% -27.55% 34.93% 39.73%
Operating Margin -236084.16% -1697351.30% -1207716.21% -29.57% -35.59%
Net Margin -235580.56% -2373421.76% -2995604.54% -24.66% -30.31%
Return on Equity (ROE) 568.95% 761.67% -273.49% -35.72% -13.81%
Return on Assets (ROA) -478.10% -535.52% -59.68% -13.06% -11.72%
Current Ratio 0.84× 0.73× 0.96× 3.06× 11.40×
Debt-to-Equity -0.00× -0.00× 2.20× 0.65× 0.11×
Cash Conversion Ratio 0.55× 0.31× 0.26× 0.54× 0.87×
Accruals Ratio -2.14× -3.71× -0.44× -0.06× -0.01×
SBC % of Revenue 113982.14% 922055.89% 555956.24% 0.25% 0.26%
CapEx Coverage -77.47× -25.71× -8.04× -62.54×
Free Cash Flow Per Share $0.00 $0.00 $0.00 $0.00

Income Statement

Concept FY 2025FY 2024FY 2024FY 2023FY 2022FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 2.98K 501 617 29.27M 13.32M
Cost of Goods and Services Sold 30.92K 66.81K 787
Gross Profit -27.94K -66.31K -170 10.22M 5.29M
Selling, General and Administrative Expense 32.22M 18.88M 10.03M
Operating Expenses 7.01M 8.44M 7.45M 18.88M 10.03M
Operating Income (Loss) -7.03M -8.50M -7.45M -8.65M -4.74M
Income Tax Expense (Benefit) 0 0
Net Income (Loss) Attributable to Parent -7.02M -11.89M -18.48M -7.22M -4.04M
Earnings Per Share, Basic $0.00 $0.00 $0.00
Weighted Average Number of Shares Outstanding, Basic 481.27B 479.70B 429.92B 339.74B 307.91B
Earnings Per Share, Diluted $0.00 $0.00 $0.00
Weighted Average Number of Shares Outstanding, Diluted 481.27B 479.70B 429.92B 339.74B 307.91B

Balance Sheet

Concept FY 2025FY 2024FY 2024FY 2023FY 2022FY 2021
Cash and Cash Equivalents, at Carrying Value 1.14M 1.19M 3.66M 26.50M
Assets, Current 1.34M 1.95M 11.73M 30.31M 28.77M
Assets 1.47M 2.22M 30.97M 55.26M 34.44M
Long-term Debt 3.56M 2.91M 3.42K
Liabilities, Current 1.59M 2.67M 12.23M 9.91M 2.52M
Long-term Debt, Excluding Current Maturities 2.40M 2.38M 815
Liabilities 1.59M 2.67M 23.10M 20.33M 5.21M
Stockholders' Equity Attributable to Parent -1.23M -1.56M 6.76M 20.21M 29.23M
Common Stock, Shares, Outstanding 525.16B 481.27B 478.27B 339.74B 339.74B

Cash Flow Statement

Concept FY 2025FY 2024FY 2024FY 2023FY 2022FY 2021
Net Cash Provided by (Used in) Operating Activities -3.88M -3.66M -4.74M -3.87M -3.53M
Payments to Acquire Property, Plant, and Equipment 47.19K 184.35K 480.93K 56.42K
Net Cash Provided by (Used in) Investing Activities -4.92M -768.55K -10.73M -87.32K
Net Cash Provided by (Used in) Financing Activities 3.37M 4.69M -13.55M 12.79M 27.19M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (HCMC CIK 0000844856), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

MNOV

MEDICINOVA, INC.

UGP

ULTRAPAR HOLDINGS INC.

CYCN

CYCLERION THERAPEUTICS, INC.